合成化合物がPPAR−γ受容体を活性化する能力を細胞ベースまたはインビトロ試験で試験した。このステップはPPAR−γ活性化剤としての潜在力を検証するために重要である。
化学原料を購入する必要がある場合は、 要求情報を送信してください最新の見積りを入手してください。
3-ethoxy-N-(p-ethoxy-phenethyl) phthalimide
C21H21NO9S
4-fluoro-2-(methoxycarbonylmethyl)benzenesulfonamide
C52H73NO13Si2
3-(4-chlorophenyl)-1-(4-nitrophenyl)-1H-pyrazole-4-carbaldehyde
2-(2,4-bis(trifluoromethyl)phenyl)ethanol
3-(2-chloro-4-hydroxyphenylethynyl)-2-methylcyclohex-2-enone
アジ化ナトリウム
二硫化炭素
5-メトキシ-1H-インドール
2H-Pyran-2-ol, 5,6-dihydro-3,5-dimethyl-6-[(1S)-1-methyl-2-(phenylmethoxy)ethyl]-, (5S,6R)-
1-phenylacetyl-4-[2-(tert-butoxycarbonylamino)acetyl]piperazine
ethyl-5-(2,4-dibenzyloxy-5-isopropylphenyl)-4-iodoisoxazole-3-carboxylate
2-butyl-6-propylphenol
3-(6-oxo-7-phenyl-6,7-dihydro-5H-[1,2,4]triazolo-[4,3-b][1,2,4]triazol-3-yl)-N-(4-sulfamoylphenyl)propionamide
4-((1-hydroxy-5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzonitrile
TVB-2640
tetra-N-benzyl-5,6-O-cyclohexylidene-tetra-N-methoxycarbonylneamin
C17H20N2O
phenyl(methoxyglycinyl) phosphorochloridate
(S)-2-(4-phenoxyphenylsulfanylmethyl)oxirane
C20H14BrN3O5
2',3',4'-trimethoxyacetanilide
2-{[4-(3,4-dichlorophenyl)-1,2,3-thiadiazol-5-yl]sulfanyl}-N-(2-fluorophenyl)acetamide
(2E,4E)-5-(1,3-benzodioxol-5-yl)-N-(3-phenylpropyl)-2,4-pentadienamide
(E)-methyl 3-(4-chlorophenyl)-2-((octylamino)methyl)acrylate
C25H28O6
trans-cinnamic pivalic anhydride
{(S)-3-Benzyloxy-1-[(2S,6R)-6-((R)-2,2-dimethyl-[1,3]dioxolan-4-ylmethyl)-tetrahydro-pyran-2-ylmethyl]-propoxy}-tert-butyl-diphenyl-silane
(1R,2S,4S,7R,SS)-(-)-bicyclo <2.2.1> hep-7-benzyloxymethyl-5-ene-2-p-toluenesulfinyl
1-METHYLISATIN, 3-THIOSEMICARBAZIDE
(3aR,4R,5R,6aS)-5-(benzoyloxy)hexahydro-4-(iodomethyl)-2H-cyclopentafuran-2-one
(Z)-5-(4-benzyloxyphenyl)methylidene-2-thioxo-4-thiazolidinone
3’-isopropyl-4’,5’-dimethoxyacetophenone
4-BroMo-5,7-diMethyl-2,3-dihydro-1H-inden-1-one
C19H28N4O3
1-Pyrrolidinecarboxylic acid, 2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-, 1,1-dimethylethyl ester, (2S)-
ベンズアルデヒドチオセミカルバゾン
THIOSEMICARBAZIDE
tert-butyl 4-(4-cyanobenzylcarbamoyl)piperidine-1-carboxylate
2-(3-(6-methylpyridin-2-yl)-4-(quinolin-6-yl)-1H-pyrazol-1-yl)-N-phenylacetamide
C18H18FN3
N-[4-(6-chloro-2-isopropylamino-pyrimidin-4-ylsulfamoyl)-phenyl]-acetamide
2-bromo-1-(3,3-difluorocyclobutyl)ethan-1-one
2(3H)-Furanone, dihydro-4-[(4-methoxyphenyl)methoxy]-, (4S)-
2-(4-nitrophenyl)-4-hydroxythieno[3,2-d]pyrimidine
4-phenoxy-2-phenylquinazoline
C27H43N3O6*ClH
Benzeneacetonitrile, a-[bis[4-[2-(diethylamino)ethoxy]phenyl]methylene]-
5,10,15,20-tetra(n-hexyl)phorphyrin